Annual Cash & Cash Equivalents
$4.68 M
-$20.00 M-81.04%
30 June 2024
Summary:
Renalytix annual cash & cash equivalents is currently $4.68 million, with the most recent change of -$20.00 million (-81.04%) on 30 June 2024. During the last 3 years, it has fallen by -$60.48 million (-92.82%). RNLX annual cash & cash equivalents is now -92.82% below its all-time high of $65.16 million, reached on 30 June 2021.RNLX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$909.00 K
-$3.77 M-80.58%
30 September 2024
Summary:
Renalytix quarterly cash and cash equivalents is currently $909.00 thousand, with the most recent change of -$3.77 million (-80.58%) on 30 September 2024. Over the past year, it has dropped by -$12.98 million (-93.46%). RNLX quarterly cash and cash equivalents is now -98.89% below its all-time high of $82.25 million, reached on 30 September 2020.RNLX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.0% | -93.5% |
| 3 y3 years | -92.8% | -98.3% |
| 5 y5 years | -42.9% | - |
RNLX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -92.8% | at low | -98.3% | at low |
| 5 y | 5 years | -92.8% | at low | -98.9% | at low |
| alltime | all time | -92.8% | +5607.3% | -98.9% | at low |
Renalytix Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $909.00 K(-80.6%) |
| June 2024 | $4.68 M(-81.0%) | $4.68 M(-0.5%) |
| Mar 2024 | - | $4.70 M(-16.3%) |
| Dec 2023 | - | $5.62 M(-59.5%) |
| Sept 2023 | - | $13.89 M(-43.7%) |
| June 2023 | $24.68 M(-40.3%) | $24.68 M(-25.3%) |
| Mar 2023 | - | $33.03 M(+38.7%) |
| Dec 2022 | - | $23.82 M(-23.3%) |
| Sept 2022 | - | $31.04 M(-24.9%) |
| June 2022 | $41.33 M | $41.33 M(+27.7%) |
| Mar 2022 | - | $32.36 M(-19.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $39.93 M(-26.5%) |
| Sept 2021 | - | $54.33 M(-16.6%) |
| June 2021 | $65.16 M(+390.2%) | $65.16 M(-7.0%) |
| Mar 2021 | - | $70.08 M(-6.0%) |
| Dec 2020 | - | $74.53 M(-9.4%) |
| Sept 2020 | - | $82.25 M(+518.8%) |
| June 2020 | $13.29 M(+62.1%) | $13.29 M(-36.1%) |
| Dec 2019 | - | $20.79 M(+153.5%) |
| June 2019 | $8.20 M(>+9900.0%) | $8.20 M(-37.4%) |
| Dec 2018 | - | $13.10 M |
| June 2018 | $82.00 K | - |
FAQ
- What is Renalytix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Renalytix?
- What is Renalytix annual cash & cash equivalents year-on-year change?
- What is Renalytix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Renalytix?
- What is Renalytix quarterly cash and cash equivalents year-on-year change?
What is Renalytix annual cash & cash equivalents?
The current annual cash & cash equivalents of RNLX is $4.68 M
What is the all time high annual cash & cash equivalents for Renalytix?
Renalytix all-time high annual cash & cash equivalents is $65.16 M
What is Renalytix annual cash & cash equivalents year-on-year change?
Over the past year, RNLX annual cash & cash equivalents has changed by -$20.00 M (-81.04%)
What is Renalytix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RNLX is $909.00 K
What is the all time high quarterly cash and cash equivalents for Renalytix?
Renalytix all-time high quarterly cash and cash equivalents is $82.25 M
What is Renalytix quarterly cash and cash equivalents year-on-year change?
Over the past year, RNLX quarterly cash and cash equivalents has changed by -$12.98 M (-93.46%)